The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Zavalko I.M.

State Research Center Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Options to enhance the efficacy of cognitive-behavior therapy of insomnia

Authors:

Zavalko I.M.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(4‑2): 36‑40

DOI: 10.17116/jnevro202112140236

Views: 1714

Downloaded: 39

Download PDF (RU)
Contact the author
Table of contents

OPTIONS TO ENHANCE THE EFFICACY OF COGNITIVE-BEHAVIOR THERAPY OF INSOMNIA
OPTIONS TO ENHANCE THE EFFICACY OF COGNITIVE-BEHAVIOR THERAPY OF INSOMNIA

To cite this article:

Zavalko IM. Options to enhance the efficacy of cognitive-behavior therapy of insomnia. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(4‑2):36‑40. (In Russ.)
https://doi.org/10.17116/jnevro202112140236

Подписка 2025-2 (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
 
МСФ на ЯМ
Close metadata
Recommended articles:
Multifocal athe­rosclerosis: epidemiology and treatment adhe­rence. Russian Journal of Preventive Medi­cine. 2024;(8):107-113

Cognitive-behavior therapy of insomnia (CBT-I) is first-line treatment for insomnia, but it produces a clinical significant result only in 60—80% of patients. Addition reason of reduction of CBT-I efficacy is a relatively low adherence: the attrition rate is 10—39%. The authors discuss options to enhance efficacy of the therapy by usage of complex approach, individualized choice of technics, motivating a patient and his relatives, and combination of CBT-I with hypnotics.

Keywords:

cognitive-behavior therapy of insomnia
treatment adherence
hypnotics

Authors:

Zavalko I.M.

State Research Center Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Received:

02.03.2021

Accepted:

18.03.2021

List of references:

  1. Riemann D, Baglioni C, Bassetti C, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675-700.  https://doi.org/10.1111/jsr.12594
  2. Qaseem A, Kansagara D, Forciea MA, et al. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2016;165(2):125-133.  https://doi.org/10.7326/M15-2175
  3. Smith MT, Perlis ML, Park A, et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry. 2002;159(1):5-11.  https://doi.org/10.1176/appi.ajp.159.1.5
  4. van Straten A, van der Zweerde T, Kleiboer A, et al. Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis. Sleep Med Rev. 2018;38:3-16.  https://doi.org/10.1016/j.smrv.2017.02.001
  5. Harvey AG, Bélanger L, Talbot L, et al. Comparative efficacy of behavior therapy, cognitive therapy, and cognitive behavior therapy for chronic insomnia: a randomized controlled trial. J Consult Clin Psychol. 2014;82(4):670-683.  https://doi.org/10.1037/a0036606
  6. Morin CM, Bootzin RR, Buysse DJ, et al. Psychological and behavioral treatment of insomnia: update of the recent evidence (1998—2004). Sleep. 2006;29(11):1398-1414. https://doi.org/10.1037/a0036606
  7. Ong JC, Kuo TF, Manber R. Who is at risk for dropout from group cognitive-behavior therapy for insomnia? J Psychosom Res. 2008;64(4):419-425.  https://doi.org/10.1016/j.jpsychores.2007.10.009
  8. Perlis M, Aloia M, Kuhn B, eds. Behavioral Treatments for Sleep Disorders: A Comprehensive Primer of Behavioral Sleep Medicine Interventions. 1st ed. Academic Press; 2011;404. 
  9. Chung KF, Lee CT, Yeung WF, et al. Sleep hygiene education as a treatment of insomnia: a systematic review and meta-analysis. Fam Pract. 2018;35(4):365-375.  https://doi.org/10.1093/fampra/cmx122
  10. Harvey L, Inglis SJ, Espie CA. Insomniacs’ reported use of CBT components and relationship to longterm clinical outcome. Behav Res Ther. 2002;40(1):75-83.  https://doi.org/10.1016/s0005-7967(01)00004-3
  11. Edinger JD, Wohlgemuth WK, Radtke RA, et al. Cognitive behavioral therapy for treatment of chronic primary insomnia: a randomized controlled trial. JAMA. 2001;285(14):1856-1864. https://doi.org/10.1001/jama.285.14.1856
  12. Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Arch Intern Med. 2004;164(17):1888-1896. https://doi.org/10.1001/archinte.164.17.1888
  13. Morin CM, Colecchi C, Stone J, et al. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA. 1999;281(11):991-999.  https://doi.org/10.1001/jama.281.11.991
  14. Sivertsen B, Omvik S, Pallesen S, et al. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial. JAMA. 2006;295(24):2851-2858. https://doi.org/10.1001/jama.295.24.2851
  15. Perlis M, Aloia M, Millikan A, et al. Behavioral treatment of insomnia: a clinical case series study J Behav Med. 2000;23(2):149-161.  https://doi.org/10.1023/a:1005413117932
  16. Vincent N, Lewycky S, Finnegan H. Barriers to engagement in sleep restriction and stimulus control in chronic insomnia. J Consult Clin Psychol. 2008;76(5):820-828.  https://doi.org/10.1037/0022-006X.76.5.820
  17. Manber R, Bernert RA, Suh S, et al. CBT for insomnia in patients with high and low depressive symptom severity: adherence and clinical outcomes. J Clin Sleep Med. 2011;7(6):645-652.  https://doi.org/10.5664/jcsm.1472
  18. McChargue DE, Sankaranarayanan J, Visovsky CG, et al. Predictors of adherence to a behavioral therapy sleep intervention during breast cancer chemotherapy. Support Care Cancer. 2012;20(2):245-252.  https://doi.org/10.1007/s00520-010-1060-1
  19. Vincent NK, Hameed H. Relation between adherence and outcome in the group treatment of insomnia. Behav Sleep Med. 2003;1(3):125-139.  https://doi.org/10.1207/S15402010BSM0103_1
  20. Hebert EA, Vincent N, Lewycky S, Walsh K. Attrition and adherence in the online treatment of chronic insomnia. Behav Sleep Med. 2010;8(3):141-150.  https://doi.org/10.1080/15402002.2010.487457
  21. Constantino MJ, Manber R, Ong J, et al. Patient expectations and therapeutic alliance as predictors of outcome in group cognitive-behavioral therapy for insomnia. Behav Sleep Med. 2007;5(3):210-228.  https://doi.org/10.1080/15402000701263932
  22. Vincent N, Lionberg C. Treatment preference and patient satisfaction in chronic insomnia. Sleep. 2001;24(4):411-417.  https://doi.org/10.1093/sleep/24.4.411
  23. Tremblay V, Savard J, Ivers H. Predictors of the effect of cognitive behavioral therapy for chronic insomnia comorbid with breast cancer. J Consult Clin Psychol. 2009;77(4):742-750.  https://doi.org/10.1037/a0015492
  24. Matthews EE, Schmiege SJ, Cook PF, et al. Adherence to cognitive behavioral therapy for insomnia (CBTI) among women following primary breast cancer treatment: a pilot study. Behav Sleep Med. 2012;10(3):217-229.  https://doi.org/10.1080/15402002.2012.666220
  25. Kyle SD, Morgan K, Spiegelhalder K, Espie CA. No pain, no gain: an exploratory within-subjects mixed-methods evaluation of the patient experience of sleep restriction therapy (SRT) for insomnia. Sleep Med. 2011;12(8):735-747.  https://doi.org/10.1016/j.sleep.2011.03.016
  26. Kyle SD, Miller CB, Rogers Z, et al. Sleep restriction therapy for insomnia is associated with reduced objective total sleep time, increased daytime somnolence, and objectively impaired vigilance: implications for the clinical management of insomnia disorder. Sleep. 2014;37(2):229-237.  https://doi.org/10.5665/sleep.3386
  27. Smith MT, Perlis ML. Who is a candidate for cognitive-behavioral therapy for insomnia? Health Psychol. 2006;25(1):15-19.  https://doi.org/10.1037/0278-6133.25.1.15
  28. Cheung J, Ji X, Morin C. Cognitive Behavioral Therapies for Insomnia and Hypnotic Medications: Considerations and Controversies. Sleep Med Clin. 2019;14(2):253-265.  https://doi.org/10.1016/j.jsmc.2019.01.006
  29. Wu R, Bao J, Zhang C, et al. Comparison of sleep condition and sleep-related psychological activity after cognitive-behavior and pharmacological therapy for chronic insomnia. Psychother Psychosom. 2006;75(4):220-228.  https://doi.org/10.1159/000092892
  30. Morin CM, Vallières A, Guay B, et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA. 2009;301(19):2005-2015. https://doi.org/10.1001/jama.2009.682
  31. Morin CM, Beaulieu-Bonneau S, Ivers H, et al. Speed and trajectory of changes of insomnia symptoms during acute treatment with cognitive-behavioral therapy, singly and combined with medication. Sleep Med. 2014;15(6):701-707.  https://doi.org/10.1016/j.sleep.2014.02.004
  32. Hauri PJ. Can we mix behavioral therapy with hypnotics when treating insomniacs? Sleep. 1997;20(12):1111-1118. https://doi.org/10.1093/sleep/20.12.1111
  33. Beaulieu-Bonneau S, Ivers H, Guay B, Morin CM. Long-Term Maintenance of Therapeutic Gains Associated with Cognitive-Behavioral Therapy for Insomnia Delivered Alone or Combined with Zolpidem. Sleep. 2017;40(3):zsx002. https://doi.org/10.1093/sleep/zsx002
  34. Zavesicka L, Brunovsky M, Horacek J, et al. Trazodone improves the results of cognitive behaviour therapy of primary insomnia in non-depressed patients. Neuro Endocrinol Lett. 2008;29(6):895-901. 
  35. Wein AM. Otchet ob issledovanii Donormila u bolnih insomniey. M. 1997. (In Russ.).
  36. Sjöqvist F, Lasagna L. The hypnotic efficacy of doxylamine. Clin Pharmacol Ther. 1967;8(1):48-54.  https://doi.org/10.1002/cpt196781part148
  37. Hausser Hauw C, Fleury B, Scheck F, et al. Effect on sleep architecture and residual effect of a dose of 15 mg of Doxylamine in healthy volunteers. Sep Hop Paris. 1995;71(23-24):742-750. 
  38. Stahl SM. Selective histamine H1 antagonism: novel hypnotic and pharmacologic actions challenge classical notions of antihistamines. CNS Spectr. 2008;13(12):1027-1038. https://doi.org/10.1017/s1092852900017089

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.